Italia markets closed

BMY Nov 2025 30.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
15,40+0,60 (+4,05%)
Alla chiusura: 02:54PM EDT
Schermo intero
Chiusura precedente14,80
Aperto15,40
Denaro15,20
Lettera15,75
Prezzo d'esercizio30,00
Scadenza2025-11-21
Min-Max giorno15,40 - 15,40
Contratto - Min-MaxN/D
Volume20
Open Interest52
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri